122 related articles for article (PubMed ID: 7519746)
1. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
[TBL] [Abstract][Full Text] [Related]
2. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
3. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen expression in central nervous system neoplasms.
Allegranza A; Girlando S; Arrigoni GL; Veronese S; Mauri FA; Gambacorta M; Pollo B; Dalla Palma P; Barbareschi M
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):417-23. PubMed ID: 1721471
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine.
Connolly KM; Bogdanffy MS
J Histochem Cytochem; 1993 Jan; 41(1):1-6. PubMed ID: 7678022
[TBL] [Abstract][Full Text] [Related]
9. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
Hoyt JW; Gown AM; Kim DK; Berger MS
J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
[TBL] [Abstract][Full Text] [Related]
10. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
11. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the time course of proliferating cell nuclear antigen and bromodeoxyuridine staining pattern in regenerating rat liver cells].
Sakiyama J; Mori S; Ichimura M; Tohge H; Okamoto M; Endo H
Rinsho Byori; 1996 Jan; 44(1):61-6. PubMed ID: 8691642
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
Zeymer U; Fishbein MC; Forrester JS; Cercek B
Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
17. Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins.
Kim DK; Hoyt J; Bacchi C; Keles GE; Mass M; Mayberg MR; Berger MS
Neurosurgery; 1993 Oct; 33(4):619-25; discussion 625-6. PubMed ID: 7901794
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
20. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]